Gefitinib is indicated as monotherapy for the continued treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of both platinum-based and docetaxel chemotherapies who are benefiting or have benefited from Gefitinib. Gefitinib may also be used for purposes other than those listed in this drug information guide.
The recommended daily dose of Gefitinib Tablets is one 250 mg tablet with or without food. Higher doses do not give a better response and cause increased toxicity. However, your oncologist may make dose adjustment as per required.
Gefitinib Side Effects
Serious side effects have been reported with the use of Gefitinib including: allergic reactions (difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives); lung problems; liver problems; eye problems; severe nausea, vomiting, loss of appetite, or diarrhoea; and others.
Gefitinib Tablets Over Dosage
Symptoms of a Gefitinib Tablet over dose tend to be similar to side effects caused by the medication, although often more severe. If you suspect over dose seek, emergency medical attention or contact your healthcare provider immediately.
Gefitinib is contraindicated in patients with severe hypersensitivity to gefitinib or to any other component of gefitinib.
The medicine information on this page is meant for Information only. It is not a substitute for medical advice. This drug may be used in treatment of diseases other then listed above. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.